Ann: Positive melanoma data for Kazia's paxalisib, page-48

Not necessarily Platinum but some group who has the same investment strategy. Low SP excellent value in terms of possibilities. Nothing has changed. FDA and registration is still a real possibility with 150 patients data soon to come. If the results from the 150 bring in the same data we already have that is game on. I thing James know this and quietly confident. People are so focused on the lack of money they fail to see the trees through the woods. That is exactly why this will get funded.